SCLSHP Gentamicin: The Good, Bad and Ugly
TYPE OF ACTIVITY/WHO SHOULD ATTEND:
This knowledge-based activity is of importance to all pharmacists.
LEARNING OBJECTIVES:
At the conclusion of this activity, pharmacists should be able to:
1. Analyze the appropriateness of gentamicin treatment in a patient
2. Describe the need for patient informed consent regarding gentamicin-induced toxicity.
3. Identify patients for clinical development of gentamicin induced nephrotoxicity and ototoxicity
FACULTY:
Gary McGarity, PharmD
FEES:
There are no fees for attendance at the meeting for LSHP members. For non-LSHP members, there will be a $10 fee for continuing education credit.
RSVP:
To Alexis Horace at 225-219-9660
SPONSORED BY: This activity is sponsored by the South Central Louisiana Society of Health-System Pharmacists.